Lixte Financial Statements From 2010 to 2021

Lixte Biotech financial statements provide useful quarterly and yearly information to potential Lixte Biotech Hlds investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Lixte Biotech financial statements helps investors assess Lixte Biotech's valuation, profitability, and current liquidity needs.
Lixte Biotech Hlds does not presently have any fundamental ratios for analysis.
.

Lixte Financial Statements 

 
Refresh
Check Lixte Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lixte main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Lixte financial statements analysis is a perfect complement when working with Lixte Biotech Valuation or Volatility modules. It can also supplement various Lixte Biotech Technical models. Check out Stocks Correlation.

Lixte Price to Book Analysis

Lixte Biotech's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
P/B 
 = 
MV Per Share 
BV Per Share 
More About Price to Book | All Equity Analysis

Current Lixte Biotech Price to Book

    
  15.25 X  
Most of Lixte Biotech's fundamental indicators, such as Price to Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lixte Biotech Hlds is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Compare to competition

Based on the latest financial disclosure, the price to book indicator of Lixte Biotech Hlds is roughly 15.25 times. This is 40.62% lower than that of the Healthcare sector and 152.48% higher than that of the Biotechnology industry. The price to book for all United States stocks is 60.36% lower than that of the firm.

Lixte Biotech Hlds Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Lixte Biotech's current stock value. Our valuation model uses many indicators to compare Lixte Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lixte Biotech competition to find correlations between indicators driving Lixte Biotech's intrinsic value. More Info.
Lixte Biotech Hlds is currently regarded as number one stock in total asset category among related companies. It is currently regarded as number one stock in return on asset category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Lixte Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lixte Biotech's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lixte Biotech's earnings, one of the primary drivers of an investment's value.

Lixte Biotech Investors Sentiment

The influence of Lixte Biotech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Lixte. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - LIXT

Lixte Biotech Hlds Investor Sentiment

Macroaxis portfolio users are evenly split in their trading attitude regarding investing in Lixte Biotech Hlds. What is your trading attitude regarding investing in Lixte Biotech Hlds? Are you bullish or bearish?
Bullish
Bearish
50% Bullish
50% Bearish
Skip

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Lixte Biotech Hlds using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Stocks Correlation. Note that the Lixte Biotech Hlds information on this page should be used as a complementary analysis to other Lixte Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Tools for Lixte Stock

When running Lixte Biotech Hlds price analysis, check to measure Lixte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotech is operating at the current time. Most of Lixte Biotech's value examination focuses on studying past and present price action to predict the probability of Lixte Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lixte Biotech's price. Additionally, you may evaluate how the addition of Lixte Biotech to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go